M&A consulting for healthcare, medicine and pharmaceuticals

Whether hospitals, pharmaceutical companies, pharmacies or physicians in private practice: the healthcare system is facing special challenges. Economic constraints, staff shortages and demographic change are currently among the most pressing challenges. With its specialized industry expertise, Steinbeis M&A can assist you in finding solutions

M&A as a solution to challenges in the healthcare sector

The healthcare industry is of enormous importance to people all over the world and remains one of the fastest growing sectors worldwide. The increasing complexity – in research as well as in regulation – is almost impossible for small companies to cope with. The key drivers for M&A activity in the healthcare sector are:

  • Demographics: An aging population and rising demand for healthcare services are driving above-average valuations.
  • Economies of scale: Mergers and acquisitions are particularly common in the healthcare sector, as economies of scale help to offset the high costs of research & development and market development more quickly.
  • Innovation: M&A transactions provide access to new technologies, products or services; they also open up new opportunities, such as digital applications (DiGA) or the e-prescription.
  • Regulatory changes: Increased legal requirements (for example, implementation of the MD Directive for medical devices) overtax smaller medium-sized companies or niche manufacturers in particular.

M&A expertise from ambulatory care to hospital and pharma

The intersection of technology and healthcare has given rise to numerous innovative business models in recent years, that facilitate or significantly improve conventional diagnostic and therapeutic procedures. The digitization of the entire healthcare industry is of significant importance and is also accelerating at a significant rate for manufacturers, customers, and patients.

Steinbeis M&A consultants have in-depth expertise on current developments in healthcare sectors such as biotechnology, pharmaceuticals, clinical and ambulatory care or digitalization – and are therefore ideally placed to offer investors and companies expert advice on transactions of all kinds. In addition, Steinbeis consultants give you access to the global Steinbeis network of 6,000 experts in more than 1,100 companies.

Steinbeis M&A divides the healthcare industry into the following areas:

  • Hospitals
  • MedTech
  • Digital Health
  • Doctors & Pharmacies
  • Pharma & Biotech
  • Care

Contact person Healthcare

E-Mail Icon Contact form
Phone Icon +49 69 1707 5761 0


"*" indicates required fields

Please fill out the form.

We will contact you as soon as possible.